These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 22262995)

  • 1. Palliative Hypofractionated Radiotherapy For Non-small-cell Lung Cancer (NSCLC) Patients Previously Treated By Induction Chemotherapy.
    A Plataniotis G; Theofanopoulou MA; Sotiriadou K; Theodorou K; Mavroidis P; Kyrgias G
    J Thorac Dis; 2009 Dec; 1(1):5-10. PubMed ID: 22262995
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Randomized phase II chemotherapy and radiotherapy trial for patients with locally advanced inoperable non-small-cell lung cancer: long-term follow-up of RTOG 92-04.
    Komaki R; Seiferheld W; Ettinger D; Lee JS; Movsas B; Sause W
    Int J Radiat Oncol Biol Phys; 2002 Jul; 53(3):548-57. PubMed ID: 12062596
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Response, toxicity, failure patterns, and survival in five Radiation Therapy Oncology Group (RTOG) trials of sequential and/or concurrent chemotherapy and radiotherapy for locally advanced non-small-cell carcinoma of the lung.
    Byhardt RW; Scott C; Sause WT; Emami B; Komaki R; Fisher B; Lee JS; Lawton C
    Int J Radiat Oncol Biol Phys; 1998 Oct; 42(3):469-78. PubMed ID: 9806503
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The International Atomic Energy Agency (IAEA) randomized trial of palliative treatment of incurable locally advanced non small cell lung cancer (NSCLC) using radiotherapy (RT) and chemotherapy (CHT) in limited resource setting.
    Jeremic B; Fidarova E; Sharma V; Faheem M; Ameira AA; Nasr Ben Ammar C; Frobe A; Lau F; Brincat S; Jones G
    Radiother Oncol; 2015 Jul; 116(1):21-6. PubMed ID: 26163093
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immediate versus delayed palliative thoracic radiotherapy in patients with unresectable locally advanced non-small cell lung cancer and minimal thoracic symptoms: randomised controlled trial.
    Falk SJ; Girling DJ; White RJ; Hopwood P; Harvey A; Qian W; Stephens RJ;
    BMJ; 2002 Aug; 325(7362):465. PubMed ID: 12202326
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inoperable non-small-cell lung cancer (NSCLC): a Medical Research Council randomised trial of palliative radiotherapy with two fractions or ten fractions. Report to the Medical Research Council by its Lung Cancer Working Party.
    Br J Cancer; 1991 Feb; 63(2):265-70. PubMed ID: 1705140
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction chemotherapy improved outcomes of patients with resectable esophageal cancer who received chemoradiotherapy followed by surgery.
    Jin J; Liao Z; Zhang Z; Ajani J; Swisher S; Chang JY; Jeter M; Guerrero T; Stevens CW; Vaporciyan A; Putnam J; Walsh G; Smythe R; Roth J; Yao J; Allen P; Cox JD; Komaki R
    Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):427-36. PubMed ID: 15380576
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prospective study of palliative hypofractionated radiotherapy (8.5 Gy x 2) for patients with symptomatic non-small-cell lung cancer.
    Cross CK; Berman S; Buswell L; Johnson B; Baldini EH
    Int J Radiat Oncol Biol Phys; 2004 Mar; 58(4):1098-105. PubMed ID: 15001250
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypofractionated palliative radiotherapy (17 Gy per two fractions) in advanced non-small-cell lung carcinoma is comparable to standard fractionation for symptom control and survival: a national phase III trial.
    Sundstrøm S; Bremnes R; Aasebø U; Aamdal S; Hatlevoll R; Brunsvig P; Johannessen DC; Klepp O; Fayers PM; Kaasa S
    J Clin Oncol; 2004 Mar; 22(5):801-10. PubMed ID: 14990635
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effectiveness of accelerated radiotherapy for patients with inoperable non-small cell lung cancer (NSCLC) and borderline prognostic factors without distant metastasis: a retrospective review.
    Nguyen LN; Komaki R; Allen P; Schea RA; Milas L
    Int J Radiat Oncol Biol Phys; 1999 Jul; 44(5):1053-6. PubMed ID: 10421538
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Medical Research Council (MRC) randomised trial of palliative radiotherapy with two fractions or a single fraction in patients with inoperable non-small-cell lung cancer (NSCLC) and poor performance status. Medical Research Council Lung Cancer Working Party.
    Br J Cancer; 1992 Jun; 65(6):934-41. PubMed ID: 1377484
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A short radiotherapy course for locally advanced non-small cell lung cancer (NSCLC): effective palliation and patients' convenience.
    Plataniotis GA; Kouvaris JR; Dardoufas C; Kouloulias V; Theofanopoulou MA; Vlahos L
    Lung Cancer; 2002 Feb; 35(2):203-7. PubMed ID: 11804694
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dose escalated, hypofractionated radiotherapy using helical tomotherapy for inoperable non-small cell lung cancer: preliminary results of a risk-stratified phase I dose escalation study.
    Adkison JB; Khuntia D; Bentzen SM; Cannon GM; Tome WA; Jaradat H; Walker W; Traynor AM; Weigel T; Mehta MP
    Technol Cancer Res Treat; 2008 Dec; 7(6):441-7. PubMed ID: 19044323
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypofractionated Image-guided Radiation Therapy (3Gy/fraction) in Patients Affected by Inoperable Advanced-stage Non-small Cell Lung Cancer After Long-term Follow-up.
    Agolli L; Valeriani M; Bracci S; Nicosia L; DE Sanctis V; Enrici RM; Osti MF
    Anticancer Res; 2015 Oct; 35(10):5693-700. PubMed ID: 26408745
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Toxicity of concurrent hyperfractionated radiation therapy and chemotherapy in locally advanced (stage III) non-small cell lung cancer (NSCLC): single institution experience in 600 patients.
    Jeremić B; Miličić B; Milisavljevic S
    Clin Transl Oncol; 2012 Aug; 14(8):613-8. PubMed ID: 22855143
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Short-course palliative radiotherapy in non-small-cell lung cancer: results of a prospective study.
    Lupattelli M; Maranzano E; Bellavita R; Chionne F; Darwish S; Piro F; Latini P
    Am J Clin Oncol; 2000 Feb; 23(1):89-93. PubMed ID: 10683087
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of lung cancer response after nonoperative therapy: tumor diameter, bidimensional product, and volume. A serial CT scan-based study.
    Werner-Wasik M; Xiao Y; Pequignot E; Curran WJ; Hauck W
    Int J Radiat Oncol Biol Phys; 2001 Sep; 51(1):56-61. PubMed ID: 11516851
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Toxicity and efficacy of a hypofractionated (3 weekly fractions of 850c Gy) irradiation schedule for stage IIIb / IV non-small cell lung cancer elderly patients with low performance status and unfit for chemotherapy.
    Kouloulias V; Patriki E; Mosa E; Platoni K; Georgakopoulos J; Zygogianni A; Dilvoi M; Patatoukas G; Antypas C; Armpilia C; Trogkanis N; Kypraiou E; Nikoloudi S; Giannakouras G; Efstathopoulos E; Kelekis N; Kouvaris J
    J BUON; 2018; 23(1):98-105. PubMed ID: 29552767
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Routine use of approximately 60 Gy once-daily thoracic irradiation for patients with limited-stage small-cell lung cancer.
    Miller KL; Marks LB; Sibley GS; Clough RW; Garst JL; Crawford J; Shafman TD
    Int J Radiat Oncol Biol Phys; 2003 Jun; 56(2):355-9. PubMed ID: 12738309
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypofractionated conformal radiotherapy in combination with chemotherapy in limited disease small cell lung cancer patients.
    Socha J; Guzowska A; Tyc-Szczepaniak D; Szczęsna A; Kępka L
    Pneumonol Alergol Pol; 2014; 82(2):105-15. PubMed ID: 24615194
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.